Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Biomechanics visualisation in ankle-foot orthoses (AFO) tuning for stroke
ISRCTN ISRCTN52126764
ClinicalTrials.gov identifier
Public title Biomechanics visualisation in ankle-foot orthoses (AFO) tuning for stroke
Scientific title Visualisation to enhance biomechanical tuning of ankle-foot orthoses (AFO) in stroke - a randomised controlled trial
Acronym N/A
Serial number at source GN10OR216
Study hypothesis Can visualisation of biomechanical data improve the tuning of ankle-foot orthoses (AFOs) for stroke patients?
Lay summary Lay summary under review
Ethics approval NHS West of Scotland Research Ethics Committee 4, 1 April 2011 Ref: 11/AL/0166
Study design Single centre single blind randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Stroke
Participants - inclusion criteria 1. In patients who have suffered a recent hemiplegia (within 1 - 12 months)
2. Aged 16 - 80 years
3. Have difficulty walking, but able to walk with/without assistance
4. Have difficulty flexing knee and extending hip during walking
5. Meet the criteria for AFO referral as outlined in AFO screening tool (Appendix 9 of NHS Scotland Best Practice Statement 'Use of AFO follwoing stroke')
6. Able to give informed consent
7. Able to attend for follow-up at 3 and 6 months
Participants - exclusion criteria 1. Unable to give informed consent
2. Unable to walk, even when assisted
3. Suffer from significant peripheral vascular disease − not suitable for fitting of AFO
4. Have any other significant medical problems likely to preclude use of AFO or follow-up
Anticipated start date 30/08/2011
Anticipated end date 28/08/2013
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 70
Interventions 1. Patients will be randomised (in blocks of six) to either the intervention or control arm of the study
2. Each arm will have its own multidisciplinary team (MDT)
3. Each of these MDTs will consist of a physiotherapist, orthotist and bioengineer
4. The relevant orthotist will then cast and fit an AFO to to the patient prior to baseline measures being taken
5. Baseline measures: All patients to have baseline gait measurements taken using 3D motion analysis
6. Intervention arm: AFO tuning aided by 3D motion anaylsis and biomechanics visualisation software
7. Control arm: AFO tuning by observation (standard care)
8. Three month measures: all patients to have baseline gait measurements taken using 3D motion analysis
9. Six month measures: all patients to have baseline gait measurements taken using 3D motion analysis
10. Duration from baseline measures will be 6 months
Primary outcome measure(s) 1. Walking velocity
2. Time taken to complete 10m walk test
Secondary outcome measure(s) 1. Lower limb joint kinematics (thigh and shank global orientations) & kinetics (knee and hip flexion/extension moments
2. Ground reaction force Fz2 peak magnitude
3. Step length
4. Gait symmetry
5. Modified Ashworth Scale
6. Abbreviated Rivermead Mobility Index
7. EuroQol (EQ-5D)
Sources of funding Medical Research Council, Lifelong Health and Wellbeing (Phase 2) Ref: G0900583, Grant ref: 91021
Trial website http://www.envisagerehab.co.uk
Publications 1. 2011 study protocol in http://www.ncbi.nlm.nih.gov/pubmed/22141471
Contact name Dr  Bruce  Carse
  Address University of Strathclyde
Bioengineering
Wolfson Building
106 Rottenrow East
  City/town Glasgow
  Zip/Postcode G4 0NW
  Country United Kingdom
  Email bruce.carse@strath.ac.uk
Sponsor University of Strathclyde (UK)
  Address c/o Ms Louise McKean (Contracts Manager)
Research & Knowledge Exchange Services
50 George Street
  City/town Glasgow
  Zip/Postcode G1 1QE
  Country United Kingdom
  Sponsor website: http://www.strath.ac.uk/
Date applied 26/05/2011
Last edited 10/01/2012
Date ISRCTN assigned 28/06/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central